期刊
EXPERIMENTAL GERONTOLOGY
卷 45, 期 1, 页码 30-40出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.exger.2009.10.010
关键词
Alzheimer's disease; MCI; Neurodegeneration; Biomarker; Prediction; Diagnosis; Blood; CSF; Tau; P-tau
资金
- Science Foundation Ireland (SFI) [08/IN.1/B1846]
- NIH [AG-10124, AG-24904]
- Swedish Research Council [2006-6227, 2006-2740]
- Alzheimer's Association [NIRG-08-90356]
- Royal Swedish Academy of Sciences [FOT-KAW09-039-A]
- NATIONAL INSTITUTE ON AGING [P30AG010124, U01AG024904] Funding Source: NIH RePORTER
Advances in our understanding of tau-mediated neurodegeneration in Alzheimer's disease (AD) are moving this disease pathway to center stage for the development of biomarkers and disease modifying drug discovery efforts. Immunoassays were developed detecting total (t-tau) and tau phosphorylated at specific epitopes (p-tauX) in cerebrospinal fluid (CSF), methods to analyse tau in blood are at the experimental beginning. Clinical research consistently demonstrated CSF t- and p-tau increased in AD compared to controls. Measuring these tau species proved informative for classifying AD from relevant differential diagnoses. Tau phosphorylated at threonine 231 (p-tau231) differentiated between AD and frontotemporal dementia, tau phosphorylated at serine 181 (p-tau181) enhanced classification between AD and dementia with Lewy bodies. T- and p-tau are considered core AD biomarkers that have been successfully validated by controlled large-scale multi-center studies. Tau biomarkers are implemented in clinical trials to reflect biological activity, mechanisms of action of compounds, support enrichment of target populations, provide endpoints for proof-of-concept and confirmatory trials on disease modification. World-wide quality control initiatives are underway to set required methodological and protocol standards. Discussions with regulatory authorities gain momentum defining the role of tau biomarkers for trial designs and how they may be further qualified for surrogate marker status. (C) 2009 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据